TrialBMJ open2017

Microvascular Outcomes after Metabolic Surgery (MOMS) in patients with type 2 diabetes mellitus and class I obesity: rationale and design for a randomised controlled trial.

Ricardo Vitor Cohen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.